{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:39:58Z","timestamp":1792658398589,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1097\/01.mbc.0000114440.81125.bd","type":"journal-article","created":{"date-parts":[[2004,6,16]],"date-time":"2004-06-16T04:00:48Z","timestamp":1087358448000},"page":"413-417","source":"Crossref","is-referenced-by-count":23,"title":["D-dimer can predict survival in patients with chronic atrial fibrillation"],"prefix":"10.1097","volume":"15","author":[{"given":"Isabelle","family":"Mah\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Simoneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Minh-Muzeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Caulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1378\/chest.119.1_suppl.194S","article-title":"Antithrombotic therapy in atrial fibrillation.","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/cs0890205","article-title":"Fibrin D-dimer: a useful clinical marker of thrombogenesis.","volume":"89","author":"Lip","year":"1995","journal-title":"Clin Sci"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.94.3.425","article-title":"Fibrin D-dimers and -thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation.","volume":"94","author":"Lip","year":"1996","journal-title":"Circulation"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0195-668X(03)00239-2","article-title":"Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.","volume":"24","author":"Roldan","year":"2003","journal-title":"Eur Heart J"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1160\/TH03-06-0363","article-title":"High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.","volume":"90","author":"Vene","year":"2003","journal-title":"Thromb Haemost"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.STR.31.4.828","article-title":"Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.","volume":"31","author":"Li-Saw-Hee","year":"2000","journal-title":"Stroke"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(02)00184-6","article-title":"D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation.","volume":"107","author":"Mahe","year":"2002","journal-title":"Thromb Res"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2000-9798","article-title":"Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons.","volume":"26","author":"Deguchi","year":"2000","journal-title":"Semin Thromb Haemost"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0037-1613831","article-title":"Haemostatic and lipids determinants of prothrombin fragment F1,2 and D-dimer in plasma.","volume":"83","author":"MacCallum","year":"2000","journal-title":"Thromb Haemost"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0037-1613566","article-title":"Fibrin(ogen) in cardiovascular disease: an update.","volume":"89","author":"Koenig","year":"2003","journal-title":"Thromb Haemost"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","article-title":"Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. A prospective randomised trial.","volume":"31","author":"Yamaguchi","year":"2000","journal-title":"Stroke"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mbc.0000114440.81125.bd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:06:17Z","timestamp":1785783977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200407000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000114440.81125.bd","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}